| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alefacept for Psoriasis
|
Heffernan, Michael P.
|
|
2010
|
29 |
1 |
p. 53-55
3 p.
|
artikel
|
| 2 |
Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
|
Gandhi, Mona
|
|
2010
|
29 |
1 |
p. 48-52
5 p.
|
artikel
|
| 3 |
Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
|
Seminara, Nicole M.
|
|
2010
|
29 |
1 |
p. 16-19
4 p.
|
artikel
|
| 4 |
Combining Traditional Systemic and Biologic Therapies for Psoriasis
|
Heffernan, Michael P.
|
|
2010
|
29 |
1 |
p. 67-69
3 p.
|
artikel
|
| 5 |
Comorbidities in Psoriasis Patients
|
Kim, Noori
|
|
2010
|
29 |
1 |
p. 10-15
6 p.
|
artikel
|
| 6 |
Introduction
|
Leonardi, Craig
|
|
2010
|
29 |
1 |
p. 1-2
2 p.
|
artikel
|
| 7 |
New Insights in the Immunologic Basis of Psoriasis
|
Nograles, Kristine E.
|
|
2010
|
29 |
1 |
p. 3-9
7 p.
|
artikel
|
| 8 |
Safety and Efficacy of the Tumor Necrosis Factor Antagonists
|
Bachmann, F.
|
|
2010
|
29 |
1 |
p. 35-47
13 p.
|
artikel
|
| 9 |
Table of Contents
|
|
|
2010
|
29 |
1 |
p. A3-A4
nvt p.
|
artikel
|
| 10 |
The Future of Biological Therapies
|
Warren, Richard B.
|
|
2010
|
29 |
1 |
p. 63-66
4 p.
|
artikel
|
| 11 |
The Role of Biologics and Other Systemic Agents in the Treatment of Pediatric Psoriasis
|
Wright, Natalie A.
|
|
2010
|
29 |
1 |
p. 20-27
8 p.
|
artikel
|
| 12 |
The Treatment of Moderate-to-Severe Psoriasis: Prescreening and Monitoring Psoriatic Patients on Biologics
|
Levine, Danielle
|
|
2010
|
29 |
1 |
p. 28-34
7 p.
|
artikel
|
| 13 |
Treatment of Psoriatic Arthritis with Biological Agents
|
Ceponis, Arnold
|
|
2010
|
29 |
1 |
p. 56-62
7 p.
|
artikel
|
Tijdschrift beschrijving